Improved Glucose Homeostasis in Mice with Muscle-Specific Deletion of Protein-Tyrosine Phosphatase 1B

REFERENCES

• Ahmad, F., and B. J. Goldstein. 1995. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44:1175–1184.
   PubMed Web of Science ®Google Scholar
• Bence, K. K., M. Delibegovic, B. Xue, C. Z. Gorgun, G. S. Hotamisligil, B. G. Neel, and B. B. Kahn. 2006. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 12:917–924.
   PubMed Web of Science ®Google Scholar
• Biddinger, S. B., and C. R. Kahn. 2006. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68:123–158.
   PubMed Web of Science ®Google Scholar
• Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
   PubMed Web of Science ®Google Scholar
• Byon, J. C., K. A. Kenner, A. B. Kusari, and J. Kusari. 1997. Regulation of growth factor-induced signaling by protein-tyrosine-phosphatases. Proc. Soc. Exp. Biol. Med. 216:1–20.
   PubMedGoogle Scholar
• Byon, J. C., A. B. Kusari, and J. Kusari. 1998. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem. 182:101–108.
   PubMed Web of Science ®Google Scholar
• Cariou, B., C. Postic, P. Boudou, R. Burcelin, C. R. Kahn, J. Girard, A. F. Burnol, and F. Mauvais-Jarvis. 2004. Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 145:1926–1932.
   PubMedGoogle Scholar
• Elchebly, M., P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran, M. J. Gresser, M. L. Tremblay, and B. P. Kennedy. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548.
   PubMed Web of Science ®Google Scholar
• Fernandez, A. M., J. K. Kim, S. Yakar, J. Dupont, C. Hernandez-Sanchez, A. L. Castle, J. Filmore, G. I. Shulman, and D. Le Roith. 2001. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 15:1926–1934.
   PubMedGoogle Scholar
• Kenner, K. A., E. Anyanwu, J. M. Olefsky, and J. Kusari. 1996. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J. Biol. Chem. 271:19810–19816.
   PubMed Web of Science ®Google Scholar
• Kim, H. J., T. Higashimori, S. Y. Park, H. Choi, J. Dong, Y. J. Kim, H. L. Noh, Y. R. Cho, G. Cline, Y. B. Kim, and J. K. Kim. 2004. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067.
   PubMed Web of Science ®Google Scholar
• Kim, J. K., M. D. Michael, S. F. Previs, O. D. Peroni, F. Mauvais-Jarvis, S. Neschen, B. B. Kahn, C. R. Kahn, and G. I. Shulman. 2000. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Investig. 105:1791–1797.
   PubMedGoogle Scholar
• Kim, Y. B., S. E. Nikoulina, T. P. Ciaraldi, R. R. Henry, and B. B. Kahn. 1999. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J. Clin. Investig. 104:733–741.
   PubMed Web of Science ®Google Scholar
• Klaman, L. D., O. Boss, O. D. Peroni, J. K. Kim, J. L. Martino, J. M. Zabolotny, N. Moghal, M. Lubkin, Y. B. Kim, A. H. Sharpe, A. Stricker-Krongrad, G. I. Shulman, B. G. Neel, and B. B. Kahn. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20:5479–5489.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K. 2005. Adipokines: therapeutic targets for metabolic syndrome. Curr. Drug Targets 6:525–529.
   PubMed Web of Science ®Google Scholar
• Lizcano, J. M., and D. R. Alessi. 2002. The insulin signalling pathway. Curr. Biol. 12:R236–R238.
   PubMed Web of Science ®Google Scholar
• Morino, K., K. F. Petersen, S. Dufour, D. Befroy, J. Frattini, N. Shatzkes, S. Neschen, M. F. White, S. Bilz, S. Sono, M. Pypaert, and G. I. Shulman. 2005. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Investig. 115:3587–3593.
   PubMed Web of Science ®Google Scholar
• Nandi, A., Y. Kitamura, C. R. Kahn, and D. Accili. 2004. Mouse models of insulin resistance. Physiol. Rev. 84:623–647.
   PubMed Web of Science ®Google Scholar
• Pei, Z., G. Liu, T. H. Lubben, and B. G. Szczepankiewicz. 2004. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity. Curr. Pharm. Des. 10:3481–3504.
   PubMed Web of Science ®Google Scholar
• Rondinone, C. M., J. M. Trevillyan, J. Clampit, R. J. Gum, C. Berg, P. Kroeger, L. Frost, B. A. Zinker, R. Reilly, R. Ulrich, M. Butler, B. P. Monia, M. R. Jirousek, and J. F. Waring. 2002. Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 51:2405–2411.
   PubMed Web of Science ®Google Scholar
• Shulman, G. I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Investig. 106:171–176.
   PubMed Web of Science ®Google Scholar
• Simoncic, P. D., C. J. McGlade, and M. L. Tremblay. 2006. PTP1B and TC-PTP: novel roles in immune-cell signaling. Can. J. Physiol. Pharmacol. 84:667–675.
   PubMedGoogle Scholar
• Taniguchi, C. M., B. Emanuelli, and C. R. Kahn. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell. Biol. 7:85–96.
   PubMed Web of Science ®Google Scholar
• Tonks, N. K. 2003. PTP1B: from the sidelines to the front lines! FEBS Lett. 546:140–148.
   PubMed Web of Science ®Google Scholar
• Waring, J. F., R. Ciurlionis, J. E. Clampit, S. Morgan, R. J. Gum, R. A. Jolly, P. Kroeger, L. Frost, J. Trevillyan, B. A. Zinker, M. Jirousek, R. G. Ulrich, and C. M. Rondinone. 2003. PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat. Mol. Cell. Endocrinol. 203:155–168.
   PubMed Web of Science ®Google Scholar
• Wu, Y., J. P. Ouyang, K. Wu, S. S. Wang, C. Y. Wen, and Z. Y. Xia. 2005. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br. J. Pharmacol. 146:234–243.
   PubMed Web of Science ®Google Scholar
• Zabolotny, J. M., F. G. Haj, Y. B. Kim, H. J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn. 2004. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J. Biol. Chem. 279:24844–24851.
   PubMed Web of Science ®Google Scholar
• Zinker, B. A., C. M. Rondinone, J. M. Trevillyan, R. J. Gum, J. E. Clampit, J. F. Waring, N. Xie, D. Wilcox, P. Jacobson, L. Frost, P. E. Kroeger, R. M. Reilly, S. Koterski, T. J. Opgenorth, R. G. Ulrich, S. Crosby, M. Butler, S. F. Murray, R. A. McKay, S. Bhanot, B. P. Monia, and M. R. Jirousek. 2002. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA 99:11357–11362.
   PubMed Web of Science ®Google Scholar
• Zisman, A., O. D. Peroni, E. D. Abel, M. D. Michael, F. Mauvais-Jarvis, B. B. Lowell, J. F. Wojtaszewski, M. F. Hirshman, A. Virkamaki, L. J. Goodyear, C. R. Kahn, and B. B. Kahn. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6:924–928.
   PubMed Web of Science ®Google Scholar